Navigating addiction treatment during COVID-19: policy insights from state health leaders.
Navigating addiction treatment during COVID-19: policy insights from state health leaders.
复制标题
COVID-19 期间的成瘾治疗导航：州卫生领导人的政策见解。
DOI：
10.1093/haschl/qxae007
复制
发表时间：
2024
期刊：
影响因子：
--
通讯作者：
McGinty,EmmaE
中科院分区：
文献类型：
--
作者：
White,SarahA;McCourt,AlexanderD;Tormohlen,KaylaN;Yu,Jiani;Eisenberg,MatthewD;McGinty,EmmaE
为了减轻与流行病相关的成瘾治疗中断，美国联邦和州政府对规范治疗提供的政策进行了重大修改。州卫生机构在实施这些政策方面发挥了关键作用，使机构领导人对大流行后政策维持的可行性和影响具有独特的Vantage。我们采访了46个州卫生机构和其他负责实施COVID-19成瘾治疗政策的领导人，这些领导人分布在人口普查地区COVID-19死亡率最高的8个州。半结构化访谈于2022年4月至10月进行。成绩单进行了分析，使用总结性内容分析，以表征政策，受访者认为，如果持续，有利于成瘾治疗提供长期。然后，通过法律的数据库查询、互联网搜索和对现有政策数据库的分析来确定国家政策的特征。国家领导人认为，大流行时期的多项政策有助于在大流行后扩大成瘾治疗的获得，包括放松对远程医疗的限制，特别是对丁丙诺啡诱导和仅音频治疗的限制;带回家的美沙酮津贴;移动的美沙酮诊所;以及州外许可的灵活性。在大流行期间，所有州都至少采取了其中一项政策。未来的研究应该在严重的COVID-19大流行背景之外评估这些政策。
To mitigate pandemic-related disruptions to addiction treatment, US federal and state governments made significant changes to policies regulating treatment delivery. State health agencies played a key role in implementing these policies, giving agency leaders a distinct vantage point on the feasibility and implications of post-pandemic policy sustainment. We interviewed 46 state health agency and other leaders responsible for implementing COVID-19 addiction treatment policies across 8 states with the highest COVID-19 death rate in their census region. Semi-structured interviews were conducted from April through October 2022. Transcripts were analyzed using summative content analysis to characterize policies that interviewees perceived would, if sustained, benefit addiction treatment delivery long-term. State policies were then characterized through legal database queries, internet searches, and analysis of existing policy databases. State leaders viewed multiple pandemic-era policies as useful for expanding addiction treatment access post-pandemic, including relaxing restrictions for telehealth, particularly for buprenorphine induction and audio-only treatment; take-home methadone allowances; mobile methadone clinics; and out-of-state licensing flexibilities. All states adopted at least 1 of these policies during the pandemic. Future research should evaluate these policies outside of the acute COVID-19 pandemic context.